*Wegovy is an FDA-approved semaglutide pill for weight loss
Guo X, Song J, Guan T et al (2015) Characterization of recombinant human gastrointestinal glutathione peroxidase mutant produced in Escherichia coli
Information about ongoing UK trials can be found via the NIHR Be Part of Research website (bepartofresearch.nihr.ac.uk) or the ClinicalTrials.gov database
In both trials, during the 10-day treatment period, subjects should not have consumed alcohol, liquids or food containing poppy seeds, grapefruit (dosing conditions trial), caffeine or other xanthines, changed their exercise pattern or daily routines (dosing conditions trial) or performed strenuous physical exercise (food-effect trial)
Accordingly, BPC-157 + TB-500 nasal sprays are easier to transport without the researcher having to worry about peptide degradation